Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
January 1, 1978
Monolateral vitelline dystrophy with unusual EOG findings
L Prosperi, M T Marsili
Oncology Reports
|
October 19, 1999
Pre-operative IL-2 immunoprophylaxis of cancer recurrence: long-term clinical results of a phase II study in radically operable colorectal cancer
F Brivio, P Lissoni, L Fumagalli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1994
A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors
P Lissoni, F Brivio, L Fumagalli, et al.
Clinical Endocrinology
|
January 1, 1980
Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride
P G Chiodini, A Liuzzi, G Verde, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|
January 1, 1978
Monolateral vitelline dystrophy with unusual EOG findings
L Prosperi, M T Marsili
Oncology Reports
|
October 19, 1999
Pre-operative IL-2 immunoprophylaxis of cancer recurrence: long-term clinical results of a phase II study in radically operable colorectal cancer
F Brivio, P Lissoni, L Fumagalli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1994
A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors
P Lissoni, F Brivio, L Fumagalli, et al.
Clinical Endocrinology
|
January 1, 1980
Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride
P G Chiodini, A Liuzzi, G Verde, et al.
Page
of 1